FDA plan would revise rules on device trials outside U.S.

02/27/2013 | GenomeWeb Daily News (free registration)

The FDA has proposed changes to its requirements for medical device clinical trials conducted outside the U.S., including mandating that manufacturers provide documentation on human subjects' informed consent as well as on trial evaluation and approval by an independent ethics panel. The proposal is up for comment through May 28.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA